[Thromboysis in the pre-hospital phase: theoretical advantage or real benefit for patient outcome?: Pro].
Henneke-Minas
G
G
Klinik und Poliklinik für Anästhesiologie und spezielle Intensivmedizin Universität Bonn.
Fischer
M
M
D004632:Emergency Medical Services; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D015912:Thrombolytic Therapy
D005343:Fibrinolytic Agents